Cogent Biosciences
COGT
COGT
73 hedge funds and large institutions have $299M invested in Cogent Biosciences in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1.06% more ownership
Funds ownership: 94.74% → 95.8% (+1.1%)
5% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 19
Holders
73
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$11.9M | |
| 2 | +$4.58M | |
| 3 | +$4.03M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$2.75M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$1.31M |
Top Sellers
| 1 | -$8.11M | |
| 2 | -$6.03M | |
| 3 | -$4.36M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$4.17M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.02M |